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Paediatricians need to be aware which
assays their local laboratories are using,
and formulate their local testing policy
accordingly.
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NICE guidance on urinary tract
infection in children abandons
routine antibiotic prophylaxis
We welcome the recommendation to dis-
continue routine antibiotic prophylaxis in
paediatric urinary tract infection, as men-
tioned in a review of the National Institute
of Health and Clinical Excellence (NICE)
guidance on this subject.1 In one of our East
London paediatric accident and emergency
departments, the incidence of trimethoprim
resistance in urinary infections increased
from 30% in 1999/2000 to over 40% in
2006/7. This is in line with an increase from
24% in 1996 to 31.6% in 2000 from another
London hospital.2 As for adults, it can be
queried whether the incidence of trimetho-
prim resistance in hospital is an accurate
reflection of community resistance.3
However, the Welsh Antimicrobial
Resistance Programme recently reported an
incidence of 26% and 27% for trimethoprim
resistance in hospital and community speci-
mens, respectively, in children under 6 years
of age. High levels of trimethoprim resis-
tance may relate, at least in part, to use of
this agent for low dose prophylaxis.
In a study, we found that 19 (86%) of 22
patients with trimethoprim resistant infec-
tions were still symptomatic after 2 days of
trimethoprim given as initial therapy while
awaiting sensitivities. In a further study, 15
(28%) of 53 patients with trimethoprim
resistant urinary infections had been given
trimethoprim previously, usually for a tri-
methoprim sensitive urine infection. An
increased risk of trimethoprim resistance
has also been shown in adult urinary tract
infections in the 3 months following tri-
methoprim treatment.4
When considering oral treatment for a
paediatric urinary tract infection, it is there-
fore advisable to establish whether trimetho-
prim has been given recently and to acquire
details of local antibiotic resistance patterns.
The incidence of resistance to nitrofurantoin
and cefalexin is 11.6% and 7.6%, respec-
tively, in our hospital patients (similar to
paediatric community rates from the Welsh
Antimicrobial Resistance Programme).
However, many children are unable to
tolerate nitrofurantoin and it is ineffective
against Proteus sp. Use of broad spectrum
antibiotics such as cefalexin may promote
antibiotic resistance and encourage growth
of Candida spp as well as enterococci and
Pseudomonas aeruginosa.
These problems emphasise the need to
avoid unnecessary use of antibiotics and to
ensure a correct diagnosis in the first
instance by obtaining at least one properly
collected clean catch urine sample before
starting treatment. The figure of 105 organ-
isms/ml quoted in the BMJ editorial accom-
panying the NICE guidance review as
indicating urinary infection, can be too high
especially for small male infants who may
pass urine frequently. Also, lower numbers
of organisms from specimens obtained by in-
out urinary catheters or ultrasound guided
supra-pubic aspirates, will still indicate
infection.
After an infection, simple general mea-
sures to reduce the risk of recurrence
(particularly for girls) include avoiding the
use of bubble baths or washing hair in the
bath.
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Probable idiopathic intracranial
hypertension in pre-pubertal
children
Idiopathic intracranial hypertension (IIH) is
characterised by disturbed cerebrospinal
fluid (CSF) hydrodynamics of unknown
aetiology.1 Diagnosis requires evidence of
an elevated CSF pressure above 20–25 cm
H2O during lumbar puncture (LP).
1 How-
ever, no consensus exists concerning what
constitutes the upper limit of normal CSF
pressure for different age groups. Therefore,
current criteria may inappropriately exclude
some children from the diagnosis of IIH and
delay the start of treatment.
We prospectively followed 25 children
with suspected IIH who were referred to
our hospital since 2004. LP with measure-
ment of CSF opening pressure was per-
formed with patients in the lateral decubitus
position. In non-cooperative children, mod-
erately deep propofol sedation was used. For
a diagnosis of IIH, Friedman criteria had to
be completely satisfied.1
In our cohort, three boys (aged 5 years
and 4 months, 7 years and 1 month, and 10
years and 11 months) and two girls (aged
8 months, and 8 years and 7 months) had
clinical manifestations consistent with IIH
but a CSF opening pressure ,20 cm H2O
and therefore did not completely meet the
inclusion criteria (table 1). Patient 1 pre-
sented with unilateral abducens nerve palsy,
which resolved after LP (no pressure
recorded). Two months later, the symptoms
reoccurred and LP demonstrated a CSF
pressure of 18 cm H2O. Again, symptoms
Table 1 HIV antibody test results of HIV uninfected infants
Number
Sample date
(months
after birth)
Result
(signal/
cut-off)*
Sample date
(months
after birth)
Result
(signal/
cut-off)
Sample date
(months
after birth)
Result (%
increase
of signal/
cut-off)
1 18.6 Positive (2.7) 22.8 Positive (1.13) 27.4 Negative
2 18.6 Positive (7.4) 22.4 Negative
3 18.1 Positive (9.3) 18.9 Positive (7.9) 21.6 Negative
4 18 Positive (2.6) 24.7 Negative
5 17.9 Positive (8.6) 26.8 Negative
6 20 Positive (6.9) 26.7 Negative
7 21.0 Positive (1.2) 23.5 Negative
8 18 Positive (1.2) 26 Negative
*Patients with an established HIV infection generally have a signal/cut-off ratio of .10 on the Genscreen Ultra screening assay.
doi:10.1136/adc.2007.133793
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resolved after pressure release. A second
relapse occurred after 10 weeks. This time,
LP demonstrated an opening pressure of
27 cm H2O. The child was put on acetazo-
lamide and remained symptom-free.
Patient 2 presented with unilateral abdu-
cens nerve palsy, which resolved after
pressure release. Four months later he
experienced a relapse. Again, abducens nerve
palsy responded well to pressure release and
he remained symptom-free under therapy
with acetazolamide. Patient 3 presented
with chronic daily headache for 6 weeks
and bilateral papilloedema. Symptoms
resolved after LP and initiation of acetazo-
lamide. Patient 4 was admitted with blurred
vision and a headache. She responded well to
pressure release and treatment with acet-
azolamide. Patient 5 presented with a head-
ache, visual obscuration and bilateral
papilloedema. Initial CSF pressure was
below 20 cm H2O, and no further treatment
was started. However, because of persisting
problems, a second LP was performed,
demonstrating a pressure of 27 cm H2O.
Symptoms resolved after pressure release
and therapy with acetazolamide.
Diagnostic criteria for IIH are well estab-
lished in adults. However, no modifications of
these criteria currently exist for children. In
the past, the upper limit of normal CSF
pressure in children has been a controversial
issue. Soler et al reported an upper limit of 7.
5 cm H2O below the age of 2 years and 13.5
below the age of 5 years.2 Kaiser and
Whitelaw, who measured CSF pressure in a
heterogeneous group of newborns, found
normal values varying from 0–7.6 cm H2O.
3
Ellis, who accessed CSF opening pressure in
children in a flexed lateral decubitus position,
found a normal range between 10–28 cm
H2O, without evidence of age or sex-related
differences.4 These discrepancies clearly
underline the need for age-adjusted normative
data. In two of our children a second LP
revealed pressure values above 20 cm H2O.
Although technical problems cannot be ruled
out with certainty, in our view this may
indicate intraindividual/circadian fluctuations
in CSF pressure.5 On the basis of our observa-
tions, we propose the introduction of the term
‘‘probable IIH’’ into clinical practice. We
define this condition as a clinical presentation
consistent with IIH in the absence of a CSF
opening pressure .20 cm H2O and a clear
clinical response to pressure release and
acetazolamide treatment (see box). Since the
feared consequence of IIH is sight loss, we
recommend a therapeutic trial with acetazo-
lamide in all children with clinical presenta-
tions that are suggestive of probable IIH.
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Long-term health outcomes of
neonatal screening for cystic
fibrosis
Balfour-Lynn’s review1 underlines the bene-
fits of neonatal screening programmes for
cystic fibrosis (CFNSP). However, long-term
clinical outcomes still need to be clarified. In
particular, only a few published studies have
compared the clinical outcomes at age 15
years of screened and non-screened cystic
fibrosis (CF) patients.2–4 In Tuscany, Italy
(3.5 million inhabitants, CF incidence 1 in
4144)5 a CFNSP has been carried out since
1984 together with a centralised follow-up
programme. We wanted to evaluate the
clinical benefits of CFNSP in an entire
population of CF patients 15 years after
diagnosis. To this purpose, we compared the
clinical conditions of CF patients born in
Tuscany since the introduction of the
CFNSP and diagnosed by screening with
those of patients followed since diagnosis by
our centre and born in the same period but
diagnosed by symptoms either due to false-
negative screening result or because they
were born in other Italian regions without a
CFNSP. Patients with meconium ileus were
excluded. Until 1991 CFNSP was performed
by the determination of albumin on dried
meconium by semiquantitative radial immu-
nodiffusion assay (with low sensitivity
(68.9%) and a high rate of false-negative
tests), followed by a protocol based on
immunoreactive trypsin assay (IRT) on
dried blood spots, which was followed, if
positive, by IRT again and a meconium
lactase test (sensitivity 94.7%). The pro-
gramme covers 99.8% of the Tuscan new-
borns.5 The diagnosis of CF was confirmed
within the third month of life with a sweat
test (Gibson and Cook method) performed
at the Regional Referral Centre in Florence.
The children diagnosed with CF were
followed by the Regional Centre or by one
of the two local CF units of Tuscany,
according to a common follow-up pro-
gramme, which includes clinical assessments
on a quarterly basis.
Sixty seven children with CF born between
1984 and 1992 were included in the study.
Thirty seven of them were diagnosed by
screening (18 females, 19 males, mean age at
diagnosis 1.7 months, SD 1.2, 10.8% DF508
homozygous, 51.3% heterozygous, 59.4%
pancreatic insufficency) and 30 were diag-
nosed by symptoms (14 females, 16 males,
mean age at diagnosis 38.3 months, SD 43,
26.6% DF508 homozygous, 40% heterozy-
gous, 60% pancreatic insufficiency). Clinical
data were retrospectively retrieved from
patients’ clinical records closest to the 15th
birthday (¡3 months).
Table 1 Children with probable idiopathic intracranial hypertension
Patient
Sex
(M/F) Age Symptoms
Ophthalmological
findings
CSF pressure
(cm H2O)
1 F 8 months NS IAP 18; 27
2 M 5 years, 4 months HE IAP 18; 20
3 M 7 years 1 month HE BP 19
4 F 8 years 7 months HE, VO BP 18
5 M 10 years 11 months HE, VO BP 17; 29
BP, bilateral papilloedema; CSF, cerebrospinal fluid; HE, headache; IAP, isolated abducens palsy; NS, no clinical symptoms;
VO, visual obscuration.
Diagnostic criteria for probable idiopathic intracranial hypertension
(1) If symptoms or signs present, they may only reflect those of generalised intracranial
hypertension or papilloedema.
(2) Cerebrospinal fluid (CSF) opening pressure may be lower than 20 cm H2O.
(3) Normal CSF composition.
(4) No evidence of hydrocephalus, mass, structural, or vascular lesion on MRI and/or MR
venography.
(5) No other cause of intracranial hypertension identified.
(6) Clear clinical response to initial pressure release.
Criteria adapted from Friedman and Jacobson (2002).1 Important modifications are highlighted in bold type.
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